mRNA |
BYL-719 |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.08 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.08 |
mRNA |
hyperforin |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.09 |
mRNA |
NSC23766 |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.09 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.09 |
mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.09 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.1 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.1 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.1 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |